Aethlon Medical, Inc. (AEMD)
1.82
-0.11
(-5.70%)
USD |
NASDAQ |
Sep 04, 16:00
1.79
-0.03
(-1.65%)
After-Hours: 20:00
Aethlon Medical Debt to Equity Ratio : 0.0707 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0707 |
| March 31, 2026 | 0.1054 |
| December 31, 2025 | 0.0622 |
| September 30, 2025 | 0.0944 |
| June 30, 2025 | 0.2006 |
| March 31, 2025 | 0.1616 |
| December 31, 2024 | 0.1672 |
| September 30, 2024 | 0.1327 |
| June 30, 2024 | 0.0998 |
| March 31, 2024 | 0.1631 |
| December 31, 2023 | 0.1327 |
| September 30, 2023 | 0.1045 |
| June 30, 2023 | 0.0873 |
| March 31, 2023 | 0.0803 |
| December 31, 2022 | 0.0737 |
| September 30, 2022 | 0.0667 |
| June 30, 2022 | 0.0467 |
| March 31, 2022 | 0.0426 |
| December 31, 2021 | 0.0165 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.0007 |
| March 31, 2021 | 0.0045 |
| December 31, 2020 | 0.0059 |
| September 30, 2020 | 0.0068 |
| June 30, 2020 | 0.0077 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.015 |
| December 31, 2019 | 0.0418 |
| September 30, 2019 | 1.257 |
| June 30, 2019 | 0.9631 |
| March 31, 2019 | 0.3968 |
| December 31, 2018 | 0.2831 |
| September 30, 2018 | 0.2185 |
| June 30, 2018 | 0.167 |
| March 31, 2018 | 0.1371 |
| December 31, 2017 | 0.1726 |
| September 30, 2017 | 7.168 |
| June 30, 2017 | -1.214 |
| March 31, 2017 | 0.7676 |
| December 31, 2016 | 5.562 |
| September 30, 2016 | -8.962 |
| June 30, 2016 | 1.424 |
| March 31, 2016 | 0.3399 |
| December 31, 2015 | 0.1581 |
| September 30, 2015 | 0.0875 |
| June 30, 2015 | 0.0489 |
| March 31, 2015 | 0.2522 |
| December 31, 2014 | 0.2357 |
| September 30, 2014 | -0.4868 |
| June 30, 2014 | -0.5078 |
| March 31, 2014 | -0.8839 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Abbott Laboratories | 0.638 |
| AngioDynamics, Inc. | 0.0641 |
| Alphatec Holdings, Inc. | 52.37 |
| AtriCure, Inc. | 0.1437 |
| Baxter International, Inc. | 1.427 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 6.235M |
| Total Liabilities (Quarterly) | 1.036M |
| Shareholders Equity (Quarterly) | 5.199M |
| Current Ratio | 5.035 |
| Net Debt Paydown Yield | 4.68% |